These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11402324)

  • 1. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
    Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
    Howard J; Ung Y; Adachi D; Ben-David Y
    Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV.
    Howard JC; Yousefi S; Cheong G; Bernstein A; Ben-David Y
    Oncogene; 1993 Oct; 8(10):2721-9. PubMed ID: 8378083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
    Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
    Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
    Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
    New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
    Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
    Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
    Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
    Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
    Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
    Lavigueur A; Bernstein A
    Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents.
    Kobayashi T; Ruan S; Clodi K; Kliche KO; Shiku H; Andreeff M; Zhang W
    Oncogene; 1998 Mar; 16(12):1587-91. PubMed ID: 9569026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-XL protects cancer cells from p53-mediated apoptosis.
    Schott AF; Apel IJ; Nuñez G; Clarke MF
    Oncogene; 1995 Oct; 11(7):1389-94. PubMed ID: 7478561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib.
    Cervi D; Truong AH; Lee JS; Sukhai N; Li YJ; Koki A; Ben-David Y
    Oncogene; 2004 Mar; 23(13):2305-14. PubMed ID: 14743207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias.
    Li YJ; Higgins RR; Pak BJ; Shivdasani RA; Ney PA; Archer M; Ben-David Y
    Mol Cell Biol; 2001 Jan; 21(1):73-80. PubMed ID: 11113182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.